NexGel, Inc. (NXGL)
0.1713
0.00 (0.00%)
USD |
NASDAQ |
Oct 06, 16:00
0.1713
0.00 (0.00%)
After-Hours: 20:00
NexGel Cash from Operations (Quarterly) : -2.197M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.197M |
| March 31, 2026 | -0.504M |
| December 31, 2025 | 0.281M |
| September 30, 2025 | -0.785M |
| June 30, 2025 | -0.407M |
| March 31, 2025 | -0.40M |
| December 31, 2024 | -0.859M |
| September 30, 2024 | -1.216M |
| June 30, 2024 | -0.70M |
| March 31, 2024 | -1.092M |
| December 31, 2023 | -0.587M |
| September 30, 2023 | -0.723M |
| June 30, 2023 | -1.217M |
| March 31, 2023 | -0.709M |
| December 31, 2022 | -0.649M |
| September 30, 2022 | -0.848M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.698M |
| March 31, 2022 | -0.797M |
| December 31, 2021 | -1.197M |
| September 30, 2021 | -0.523M |
| June 30, 2021 | -0.688M |
| March 31, 2021 | -0.345M |
| December 31, 2020 | -0.423M |
| September 30, 2020 | -0.398M |
| June 30, 2020 | -0.32M |
| March 31, 2020 | -0.66M |
| December 31, 2019 | -0.387M |
| September 30, 2019 | -0.268M |
| June 30, 2019 | -0.603M |
| March 31, 2019 | -0.556M |
| December 31, 2018 | 0.267M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 347.16M |
| Neogen Corp. | 30.20M |
| QuidelOrtho Corp. | -110.60M |
| Aspira Women's Health, Inc. | -2.01M |
| Biomerica, Inc. | -0.912M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -6.578M |
| Cash from Financing (Quarterly) | 8.359M |
| Free Cash Flow | -3.338M |
| Free Cash Flow Per Share (Quarterly) | -0.2522 |
| Free Cash Flow to Equity (Quarterly) | -5.445M |
| Free Cash Flow to Firm (Quarterly) | -0.047M |
| Free Cash Flow Yield | -233.8% |